Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
2 clinical trials · Condition
◉ Watch Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Study Evaluating Safety and Efficacy of C-CAR011 in Subjects With B-NHL (NCT03299738) | Shanghai AbelZeta Ltd. | 2017-12-01 |
Track Refractory or Relapsed B-cell Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.